Concentrix Corp. (CNXC) intrinsic value & 10-year financials
Concentrix Corp. (CNXC) has a Graham intrinsic value of $110.75 per share. At $27.87 on Oct 17, 2026, the stock trades 75% below that value. Over the last 8 fiscal years revenue grew 13.1% a year to $9.8B, with an average return on invested capital of 5.8%.
- Graham intrinsic value
- $110.75
- Share price (Oct 17, 2026)
- $27.87
- Price vs Graham value
- 75% below
- Market cap
- $1.8B
- Revenue (FY2025)
- $9.8B
- Revenue growth (8-yr CAGR)
- 13.1%
- ROIC (10-yr avg)
- 5.8%
- Free cash flow (FY2025)
- $572.5M
CNXC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $9.8B | -$1.3B | -$20.36 | $572.5M | -9.3% | -10.9% |
| FY2024 | $9.6B | $251.2M | $3.71 | $428.7M | 6.2% | 5.4% |
| FY2023 | $7.1B | $313.8M | $5.70 | $497.5M | 9.3% | 7.0% |
| FY2022 | $6.3B | $435.0M | $8.28 | $460.7M | 10.1% | 10.6% |
| FY2021 | $5.6B | $405.6M | $7.70 | $365.1M | 10.2% | 11.5% |
| FY2020 | $4.7B | $164.8M | $3.19 | $336.3M | 6.5% | 5.2% |
| FY2019 | $4.7B | $117.2M | $2.27 | $338.6M | 6.3% | 12.1% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Concentrix Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Concentrix Corp has historically struggled to out-earn its cost of capital, averaging just 5.8% ROIC.
Concentrix Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Concentrix Corp is modeled at 13.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $110.75 per share.